mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.004 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.005 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.005 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.007 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.007 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.007 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.008 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.009 |